Nagaoka Red Cross Hospital   Report issue

Academic/Hospital
Founded: Nagaoka Japan (1931)

Organization Overview

First Clinical Trial
2012
NCT01642108
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

incretin (1 trial)

sitagliptin (januvia) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2